Close Menu
    Facebook X (Twitter) Instagram
    SciTechDaily
    • Biology
    • Chemistry
    • Earth
    • Health
    • Physics
    • Science
    • Space
    • Technology
    Facebook X (Twitter) Pinterest YouTube RSS
    SciTechDaily
    Home»Health»New Research Finds Key Differences Between Children & Adults With COVID-19
    Health

    New Research Finds Key Differences Between Children & Adults With COVID-19

    By National Institute of Allergy and Infectious DiseasesOctober 17, 2023No Comments4 Mins Read
    Facebook Twitter Pinterest Telegram LinkedIn WhatsApp Email Reddit
    Share
    Facebook Twitter LinkedIn Pinterest Telegram Email Reddit
    Colorized Scanning Electron Micrograph of a Cell Infected With the Omicron Strain of SARS CoV 2 Virus Particles
    Colorized scanning electron micrograph of a cell (purple) infected with the Omicron strain of SARS-CoV-2 virus particles (green), isolated from an individual. Image captured at the NIAID Integrated Research Facility in Fort Detrick, Maryland. Credit: NIAID

    Recent findings shed light on why younger children exhibit fewer severe COVID-19 symptoms compared to adults. The study observed that infants and young children who contracted SARS-CoV-2 had a strong, sustained antibody response to the virus and high levels of inflammatory proteins in the nose but not in the blood. This immune response contrasts with that typically seen in adults with SARS-CoV-2 infection. Co-funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, the research appears in the journal Cell.  

    Study Methodology and Participants

    The investigation involved 81 full-term infants and young children whose mothers enrolled in a NIAID-supported cohort study at Cincinnati Children’s during their third trimester of pregnancy. The study team trained mothers to collect weekly nasal swabs from their infants starting when the babies were 2 weeks old. The team also drew blood from the babies regularly, starting at age 6 weeks, as well as when the children became infected with SARS-CoV-2 and during subsequent weeks and months.

    These samples enabled the scientists to study the children’s immune responses before, during, and after they were exposed to the virus for the first time. Fifty-four of the children became infected and had mild COVID-19, while 27 who tested negative through the study period served as matched controls. At the time of infection, the children were 1 month to nearly 4 years old, and half were 9 months or younger. The study also included weekly nasal swabs from 19 mothers with COVID-19 and 19 healthy mothers as controls, as well as blood samples from 89 adults with COVID-19 and 13 healthy controls.

    Key Findings: Child vs. Adult Immune Response

    The researchers examined many aspects of the babies’ and adults’ immune responses to the virus through an approach called systems immunology. The study revealed that young children’s antibody response to SARS-CoV-2 differs from that of adults. Typically, adults produce antibodies to the virus at levels that spike for a few weeks, then decline. In contrast, the infants and young children in the study produced protective antibodies at levels that spiked and remained high for up to the full 300-day observation period. 

    The scientists also found that the blood of adults with SARS-CoV-2 infection typically had high levels of proteins called inflammatory cytokines, which are associated with severe COVID-19 and death, while the blood of babies and children did not. However, the children’s noses had high levels of inflammatory cytokines and a potent antiviral cytokine.

    Implications and Recommendations

    According to the researchers, these findings suggest that cytokines snuffed out SARS-CoV-2 infection right at the site where the virus entered the children’s bodies, potentially explaining the mildness of their COVID-19 disease. The findings also suggest it may be possible to devise vaccine adjuvants that mimic the immune responses observed in young children by stimulating persistently high antibody levels without causing dangerous excess inflammation in the blood.   

    Children aged 6 months to 4 years who got COVID-19 vaccines before September 12, 2023, should get one or two doses of updated COVID-19 vaccine, depending on which vaccine and how many doses they previously received. Children aged 6 months to 4 years who have not been vaccinated should get two or three doses of the updated COVID-19 vaccine, depending on which vaccine they receive. 

    Reference: “Multi-omics analysis of mucosal and systemic immunity to SARS-CoV-2 after birth” by Florian Wimmers, Allison R. Burrell, Yupeng Feng, Hong Zheng, Prabhu S. Arunachalam, Mengyun Hu, Sara Spranger, Lindsay E. Nyhoff, Devyani Joshi, Meera Trisal, Mayanka Awasthi, Lorenza Bellusci, Usama Ashraf, Sangeeta Kowli, Katherine C. Konvinse, Emily Yang, Michael Blanco, Kathryn Pellegrini, Gregory Tharp, Thomas Hagan, R. Sharon Chinthrajah, Tran T. Nguyen, Alba Grifoni, Alessandro Sette, Kari C. Nadeau, David B. Haslam, Steven E. Bosinger, Jens Wrammert, Holden T. Maecker, Paul J. Utz, Taia T. Wang, Surender Khurana, Purvesh Khatri, Mary A. Staat and Bali Pulendran, 29 September 2023, Cell.
    DOI: 10.1016/j.cell.2023.08.044

    Bali Pulendran, Ph.D., and Mary Allen Staat, M.D., M.P.H., led the study. Dr. Pulendran is the Violetta L. Horton Professor and co-director of the Institute for Immunology, Transplantation and Infection at Stanford University in California. Dr. Staat is the Kulkarni Endowed Chair in Infectious Diseases and a professor of pediatric infectious diseases at Cincinnati Children’s.

    Never miss a breakthrough: Join the SciTechDaily newsletter.
    Follow us on Google and Google News.

    Children COVID-19 Immune System National Institute of Allergy and Infectious Diseases Popular
    Share. Facebook Twitter Pinterest LinkedIn Email Reddit

    Related Articles

    Additional “Booster” Dose of COVID-19 Vaccine Found Safe, Immunogenic in Mix-and-Match Trial

    Genetic Research Shows Rapid Immune Response in Children Protects Them From COVID-19

    Lung Autopsies of COVID-19 Patients Reveal How Virus Spreads and Damages Tissue, Treatment Clues

    NIAID Issues New Awards To Fund “Pan-Coronavirus” Vaccines – Primary Focus on Potential Pandemic-Causing Viruses

    U.S. Begins Phase 3 Clinical Trial of COVID-19 Vaccine

    NIH Begins Clinical Trial of Hydroxychloroquine and Azithromycin to Treat COVID-19

    COVID-19 Recovery: Researchers Find the Immune System Can Fight Back

    New Coronavirus That Causes COVID-19 Is Stable for Hours on Surfaces

    Why Are Bat Viruses So Deadly? Answers to the Question Raised by Coronavirus Outbreak

    Leave A Reply Cancel Reply

    • Facebook
    • Twitter
    • Pinterest
    • YouTube

    Don't Miss a Discovery

    Subscribe for the Latest in Science & Tech!

    Trending News

    Hidden Brain Signals Could Predict Alzheimer’s Years Before Symptoms Appear

    The Solar System May Have a 6th Dwarf Planet – and It’s Been Hiding in Plain Sight

    New Research Identifies the Hidden Rules That Help Brain Cancer Evade Treatment

    Smiling Isn’t Always Good for You, Scientists Discover

    Scientists Discover Climate Change May Have Stopped Earth’s Next Ice Age

    Quantum Discovery Reveals Why More Powerful Lasers Can Actually Slow Atoms Down

    Einstein Was Right Again: Scientists Discover Chemical Bonds That Defy Textbook Rules

    NASA Space Telescope Meets Fiery End After Nearly 22 Years in Orbit

    Follow SciTechDaily
    • Facebook
    • Twitter
    • YouTube
    • Pinterest
    • Newsletter
    • RSS
    SciTech News
    • Biology News
    • Chemistry News
    • Earth News
    • Health News
    • Physics News
    • Science News
    • Space News
    • Technology News
    Recent Posts
    • Why Did Polynesians Suddenly Sail Across the Pacific After 1,700 Years? Scientists May Have Found the Answer
    • A Natural “Varnish” May Explain How 37,000-Year-Old Cave Art Survived
    • Scientists Just Found a Key Ingredient for Superconductivity at Room Temperature
    • Scientists Discover a Hidden Weakness in One of the Deadliest Cancers
    • Could Vitamin B12 Hold the Key to Treating a Rare Genetic Disorder?
    Copyright © 1998 - 2026 SciTechDaily. All Rights Reserved.
    • Science News
    • About
    • Contact
    • Editorial Board
    • Privacy Policy
    • Terms of Use

    Type above and press Enter to search. Press Esc to cancel.